HF600 (Winkler) Cannabis; various provisions modified relating to Cannabis Management Board; advisory councils; use and sales reports; legalization and limitation of adult possession and use; licensing, inspection, and regulation of cannabis businesses; testing; labeling; advertising; private residence cultivation; medical program regulatory authority; taxation; grant and loan programs; criminal penalties; expungement procedures; labor standards; nuisance cause of action; scheduling; data; and money appropriated.
*Amendments to HF600 are due by 5:00pm, Friday, April 9, 2021.
**PLEASE NOTE: Testimony, amendments, and discussion will be limited to provisions of the bill within the jurisdiction of the Environment and Natural Resources Finance and Policy Committee. The provisions are as follows:
Article 1
• Secs. 2 and 3 – establishing the Board and Advisory Council
• Sec. 7 – environmental standards
• Sec. 14 – license selection criteria (particularly subdivision 3)
• Sec. 15 – inspection and licensing enforcement
• Sec. 16 – license suspension/revocation and hearings
• Sec. 18 – general operation requirements (particularly subdivisions 4, 5, and 8)
• Sec. 19 – cultivator licensing (particularly subdivision 2)
• Sec. 20 – cultivator operations (particularly subdivision 3)
• Sec. 21 – manufacturer licensing (particularly subdivision 2)
• Sec. 22 – manufacturer operations (particularly subdivision 2)
• Sec. 23 – retailer licensing (particularly subdivision 2)
• Sec. 25 – wholesaler licensing (particularly subdivision 2)
• Sec. 28 – transporter operations (particularly subdivision 1)
• Sec. 29 – testing facility licensing (particularly subdivision 2)
• Sec. 30 – testing facility operations (particularly subdivision 4)
• Sec. 31 – microbusiness licensing (particularly subdivision 2)
• Sec. 32 – microbusiness operations (particularly subdivision 1, 2, and 3)
• Sec. 33 – even organizer licensing (particularly subdivision 2)
• Sec. 34 – even organizer licensing (particularly subdivision 5)
• Sec. 37 – medical cannabis licensing (particularly subdivision 2)
• Sec. 38 – medical cannabis operations (particularly subdivisions 1, 2, 3, and 4)
• Sec. 39 – legacy medical cannabis manufacturers (particularly subdivision 4)
Article 9
• Sec. 1, sub. 7 – DNR funding
This remote hearing is taking place pursuant to Rule 10.01, which you may view here:
https://www.house.leg.state.mn.us/cco/rules/permrule/permrule.asp
This remote hearing may be viewed via the House webcast schedule page:
https://www.house.leg.state.mn.us/htv/schedule.asp NOTE: HTV 1 and HTV 2 will provide live closed captioning. Video archives of meetings streamed on HTV 3, 4, and 5 will have closed captions added. Other reasonable accessibility accommodations may be made with advance notice.
If you have questions about the accessibility of remote hearings or require an accommodation, please contact Jenny Nash at:
jenny.nash@house.mn or by leaving a message at 651-296-4122. Please do not contact her with questions about the substance of the meeting agenda.
Any meeting documents will be posted on the House Environment and Natural Resources Finance and Policy committee website at
https://www.house.leg.state.mn.us/Committees/Home/92007
Public Testimony:
• If you wish to testify, please contact
Peter.Strohmeier@house.mn and copy
Adam.Kopel@house.mn by 3:00pm, Sunday, April 11, 2021. Please note: Public testimony on HF 600 should be related to issues within the jurisdiction of the Environment and Natural Resources Finance and Policy Committee and will be limited to 20 minutes total for supporters and 20 minutes total for those in opposition. Testimony may be limited to 1-2 minutes.
• If you plan to submit written testimony, please send to
Peter.Strohmeier@house.mn by 5:00pm, Friday, April 9, 2021.